In a research report released Monday, H.C.
Roth Capital’s healthcare analyst Michael Higgins weighed in with a few insights on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company announced that it held an informal meeting …
MannKind Corporation (NASDAQ:MNKD) fell 10.07% in pre-market trading to $3.
After repeat attempts to convince the U.S.
In a research report released Tuesday, Cowen analyst Boris Peaker reiterated a Market Perform rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company released …
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today …
In a research report issued Friday, Roth Capital analyst Michael Higgins reiterated a Buy rating on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a …
In a research report released yesterday, Roth Capital analyst Michael Higgins resumed coverage on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a Buy rating and a …
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and …
